Journal Home > Volume 5 , Issue 4

Increases in depressive behaviors have been reported in patients experiencing chronic pain. In these patients, the symptoms of pain and depression commonly coexist, impairing their lives and challenging effective treatment. The hippocampus may play a role in both chronic pain and depression. A reduction in the volume of the hippocampus is related to reduced neurogenesis and neuroplasticity in cases of chronic pain and depression. Moreover, an increase of proinflammatory factors and a reduction of neurotrophic factors have been reported to modulate the hippocampal neurogenesis and neuroplasticity in chronic pain and depression. This review discusses the mechanisms underlying the depressive-like behavior accompanying chronic pain, emphasizing the structural and functional changes in the hippocampus. We also discuss the hypothesis that pro-inflammatory factors and neurotrophic factors expressed in the hippocampus may serve as a therapeutic target for comorbid chronic pain and depression.


menu
Abstract
Full text
Outline
About this article

Involvement of the hippocampus in chronic pain and depression

Show Author's information Tahmineh Mokhtari1,2Yiheng Tu3Li Hu1,2( )
CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China
Department of Psychology, University of Chinese Academy of Sciences, Beijing 100101, China
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA

Abstract

Increases in depressive behaviors have been reported in patients experiencing chronic pain. In these patients, the symptoms of pain and depression commonly coexist, impairing their lives and challenging effective treatment. The hippocampus may play a role in both chronic pain and depression. A reduction in the volume of the hippocampus is related to reduced neurogenesis and neuroplasticity in cases of chronic pain and depression. Moreover, an increase of proinflammatory factors and a reduction of neurotrophic factors have been reported to modulate the hippocampal neurogenesis and neuroplasticity in chronic pain and depression. This review discusses the mechanisms underlying the depressive-like behavior accompanying chronic pain, emphasizing the structural and functional changes in the hippocampus. We also discuss the hypothesis that pro-inflammatory factors and neurotrophic factors expressed in the hippocampus may serve as a therapeutic target for comorbid chronic pain and depression.

Keywords: depression, hippocampus, chronic pain, proinflammatory cytokines, brain-derived neurotrophic factor

References(93)

[1]
PA Boakye, C Olechowski, S Rashiq, et al. A critical review of neurobiological factors involved in the interactions between chronic pain, depression, and sleep disruption. Clin J Pain. 2016, 32(4): 327-336.
[2]
XY Li, L Hu. The role of stress regulation on neural plasticity in pain chronification. Neural Plast. 2016, 2016: 6402942.
[3]
L Zhang, LL Zhou, QY Ren, et al. Evaluating cortical alterations in patients with chronic back pain using neuroimaging techniques: recent advances and perspectives. Front Psychol. 2019, 10: 2527.
[4]
CJ Phillips. The cost and burden of chronic pain. Rev Pain. 2009, 3(1): 2-5.
[5]
NN Burke, DP Finn, M Roche. Neuroinflammatory mechanisms linking pain and depression. In Pain in Psychiatric Disorders. DP Finn, BE Leonard, Eds. Basel: Karger, 2015.
[6]
AA Mutso, D Radzicki, MN Baliki, et al. Abnormalities in hippocampal functioning with persistent pain. J Neurosci. 2012, 32(17): 5747-5756.
[7]
RG Torta, J Munari. Symptom cluster: Depression and pain. Surg Oncol. 2010, 19(3): 155-159.
[8]
M von Korff, SF Dworkin, L Le Resche, et al. An epidemiologic comparison of pain complaints. Pain. 1988, 32(2): 173-183.
[9]
PL Delgado. Common pathways of depression and pain. J Clin Psychiatry. 2004, 65(12):16-19.
[10]
KT Martucci, SC Mackey. Neuroimaging of pain: human evidence and clinical relevance of central nervous system processes and modulation. Anesthesiology. 2018, 128(6): 1241-1254.
[11]
JE Brown, N Chatterjee, J Younger, et al. Towards a physiology-based measure of pain: patterns of human brain activity distinguish painful from non-painful thermal stimulation. PLoS One. 2011, 6(9): e24124.
[12]
S Leknes, I Tracey. A common neurobiology for pain and pleasure. Nat Rev Neurosci. 2008, 9(4): 314-320.
[13]
KS Anand, V Dhikav. Hippocampus in health and disease: an overview. Ann Indian Acad Neurol. 2012, 15(4): 239-246.
[14]
S Yang, MC Chang. Chronic pain: structural and functional changes in brain structures and associated negative affective states. Int J Mol Sci. 2019, 20(13): E3130.
[15]
MF Vaculik, A Noorani, PS Hung, et al. Selective hippocampal subfield volume reductions in classic trigeminal neuralgia. Neuroimage Clin. 2019, 23: 101911.
[16]
ME Zimmerman, JW Pan, HP Hetherington, et al. Hippocampal correlates of pain in healthy elderly adults: a pilot study. Neurology. 2009, 73(19): 1567-1570.
[17]
K Sawyer, E Corsentino, N Sachs-Ericsson, et al. Depression, hippocampal volume changes, and cognitive decline in a clinical sample of older depressed outpatients and non-depressed controls. Aging Ment Health. 2012, 16(6): 753-762.
[18]
GM MacQueen, K Yucel, VH Taylor, et al. Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biol Psychiatry. 2008, 64(10): 880-883.
[19]
SW Chan, CJ Harmer, R Norbury, et al. Hippocampal volume in vulnerability and resilience to depression. J Affect Disord. 2016, 189: 199-202.
[20]
M Grilli. Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies. J Pain Res. 2017, 10: 2281-2286.
[21]
JY Sheng, S Liu, YC Wang, et al. The link between depression and chronic pain: neural mechanisms in the brain. Neural Plast. 2017, 2017: 9724371.
[22]
A del Rey, AV Apkarian, M Martina, et al. Chronic neuropathic pain-like behavior and brain-borne IL-1β. Ann N Y Acad Sci. 2012, 1262: 101-107.
[23]
A del Rey, HJ Yau, A Randolf, et al. Chronic neuropathic pain-like behavior correlates with IL-1β expression and disrupts cytokine interactions in the hippocampus. Pain. 2011, 152(12): 2827-2835.
[24]
RT Martuscello, RN Spengler, AC Bonoiu, et al. Increasing TNF levels solely in the rat hippocampus produces persistent pain-like symptoms. Pain. 2012, 153(9): 1871-1882.
[25]
L Doan, T Manders, J Wang. Neuroplasticity underlying the comorbidity of pain and depression. Neural Plast. 2015, 2015: 504691.
[26]
PH Hilderink, H Burger, DJ Deeg, et al. The temporal relation between pain and depression: results from the longitudinal aging study Amsterdam. Psychosom Med. 2012, 74(9): 945-951.
[27]
SF Lerman, Z Rudich, S Brill, et al. Longitudinal associations between depression, anxiety, pain, and pain-related disability in chronic pain patients. Psychosom Med. 2015, 77(3): 333-341.
[28]
MM Ohayon, AF Schatzberg. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry. 2003, 60(1): 39-47.
[29]
LR Miller, A Cano. Comorbid chronic pain and depression: who is at risk? J Pain. 2009, 10(6): 619-627.
[30]
L Agüera-Ortiz, I Failde, JA Mico, et al. Pain as a symptom of depression: prevalence and clinical correlates in patients attending psychiatric clinics. J Affect Disord. 2011, 130(1/2): 106-112.
[31]
P Lee, MY Zhang, JP Hong, et al. Frequency of painful physical symptoms with major depressive disorder in Asia: relationship with disease severity and quality of life. J Clin Psychiatry. 2009, 70(1): 83-91.
[32]
MJ Bair, RL Robinson, GJ Eckert, et al. Impact of pain on depression treatment response in primary care. Psychosom Med. 2004, 66(1): 17-22.
[33]
GF Zhang, J Wang, JF Han, et al. Acute single dose of ketamine relieves mechanical allodynia and consequent depression-like behaviors in a rat model. Neurosci Lett. 2016, 631: 7-12.
[34]
PD Smith, K Becker, L Roberts, et al. Associations among pain, depression, and functional limitation in low-income, home-dwelling older adults: an analysis of baseline data from CAPABLE. Geriatr Nurs. 2016, 37(5): 348-352.
[35]
J Wang, Y Goffer, D Xu, et al. A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology. 2011, 115(4): 812-821.
[36]
MD Leitl, S Onvani, MS Bowers, et al. Pain-related depression of the mesolimbic dopamine system in rats: expression, blockade by analgesics, and role of endogenous κ-opioids. Neuropsychopharmacology. 2014, 39(3): 614-624.
[37]
CP Mao, ZL Bai, XN Zhang, et al. Abnormal subcortical brain morphology in patients with knee osteoarthritis: a cross-sectional study. Front Aging Neurosci. 2016, 8: 3.
[38]
AR Mansour, MA Farmer, MN Baliki, et al. Chronic pain: the role of learning and brain plasticity. Restor Neurol Neurosci. 2014, 32(1): 129-139.
[39]
S Khanna, JG Sinclair. Noxious stimuli produce prolonged changes in the CA1 region of the rat hippocampus. Pain. 1989, 39(3): 337-343.
[40]
P Dutar, Y Lamour, A Jobert. Activation of identified septo-hippocampal neurons by noxious peripheral stimulation. Brain Res. 1985, 328(1): 15-21.
[41]
V Duric, KE McCarson. Persistent pain produces stress-like alterations in hippocampal neurogenesis and gene expression. J Pain. 2006, 7(8): 544-555.
[42]
BD Dick, S Rashiq. Disruption of attention and working memory traces in individuals with chronic pain. Anesth Analg. 2007, 104(5): 1223-1229.
[43]
RP Hart, MF Martelli, ND Zasler. Chronic pain and neuropsychological functioning. Neuropsychol Rev. 2000, 10(3): 131-149.
[44]
E Awh, EK Vogel, SH Oh. Interactions between attention and working memory. Neuroscience. 2006, 139(1): 201-208.
[45]
C Eccleston. Chronic pain and distraction: an experimental investigation into the role of sustained and shifting attention in the processing of chronic persistent pain. Behav Res Ther. 1995, 33(4): 391-405.
[46]
D Kodama, H Ono, M Tanabe. Increased hippocampal glycine uptake and cognitive dysfunction after peripheral nerve injury. Pain. 2011, 152(4): 809-817.
[47]
WJ Ren, Y Liu, LJ Zhou, et al. Peripheral nerve injury leads to working memory deficits and dysfunction of the hippocampus by upregulation of TNF-α in rodents. Neuropsychopharmacology. 2011, 36(5): 979-992.
[48]
AR Preston, H Eichenbaum. Interplay of hippocampus and prefrontal cortex in memory. Curr Biol. 2013, 23(17): R764-R773.
[49]
RP Hart, JB Wade, MF Martelli. Cognitive impairment in patients with chronic pain: the significance of stress. Curr Pain Headache Rep. 2003, 7(2): 116-126.
[50]
MN Raftery, K Sarma, AW Murphy, et al. Chronic pain in the Republic of Ireland—community prevalence, psychosocial profile and predictors of pain-related disability: results from the Prevalence, Impact and Cost of Chronic Pain (PRIME) study, part 1. Pain. 2011, 152(5): 1096-1103.
[51]
O Gureje, M von Korff, GE Simon, et al. Persistent pain and well-being: a world health organization study in primary care. JAMA. 1998, 280(2): 147-151.
[52]
NV Malykhin, R Carter, P Seres, et al. Structural changes in the hippocampus in major depressive disorder: contributions of disease and treatment. J Psychiatry Neurosci. 2010, 35(5): 337-343.
[53]
M Terada, N Kuzumaki, N Hareyama, et al. Suppression of enriched environment-induced neurogenesis in a rodent model of neuropathic pain. Neurosci Lett. 2008, 440(3): 314-318.
[54]
S Ijaz, I Mohammed, M Gholaminejhad, et al. Modulating pro-inflammatory cytokines, tissue damage magnitude, and motor deficit in spinal cord injury with subventricular zone-derived extracellular vesicles. J Mol Neurosci. 2020, 70(3): 458-466.
[55]
LC Abbott, F Nigussie. Adult neurogenesis in the mammalian dentate gyrus. Anat Histol Embryol. 2020, 49(1): 3-16.
[56]
W Deng, JB Aimone, FH Gage. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci. 2010, 11(5): 339-350.
[57]
JM Revest, D Dupret, M Koehl, et al. Adult hippocampal neurogenesis is involved in anxiety-related behaviors. Mol Psychiatry. 2009, 14(10): 959-967.
[58]
A Sahay, RN Hen. Adult hippocampal neurogenesis in depression. Nat Neurosci. 2007, 10(9): 1110-1115.
[59]
A Dranovsky, R Hen. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry. 2006, 59(12): 1136-1143.
[60]
MD Saxe, F Battaglia, JW Wang, et al. Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus. Proc Natl Acad Sci USA. 2006, 103(46): 17501-17506.
[61]
W Liu, TT Ge, YS Leng, et al. The role of neural plasticity in depression: from hippocampus to prefrontal cortex. Neural Plast. 2017, 2017: 6871089.
[62]
J Zheng, YY Jiang, LC Xu, et al. Adult hippocampal neurogenesis along the dorsoventral axis contributes differentially to environmental enrichment combined with voluntary exercise in alleviating chronic inflammatory pain in mice. J Neurosci. 2017, 37(15): 4145-4157.
[63]
AA Lempel, L Coll, AF Schinder, et al. Chronic pregabalin treatment decreases excitability of dentate gyrus and accelerates maturation of adult-born granule cells. J Neurochem. 2017, 140(2): 257-267.
[64]
EL Dimitrov, MC Tsuda, HA Cameron, et al. Anxiety- and depression-like behavior and impaired neurogenesis evoked by peripheral neuropathy persist following resolution of prolonged tactile hypersensitivity. J Neurosci. 2014, 34(37): 12304-12312.
[65]
KP Westlake, NN Byl. Neural plasticity and implications for hand rehabilitation after neurological insult. J Hand Ther. 2013, 26(2): 87-93.
[66]
V Fasick, RN Spengler, S Samankan, et al. The hippocampus and TNF: Common links between chronic pain and depression. Neurosci Biobehav Rev. 2015, 53: 139-159.
[67]
AV Apkarian, AA Mutso, MV Centeno, et al. Role of adult hippocampal neurogenesis in persistent pain. Pain. 2016, 157(2): 418-428.
[68]
A Dellarole, P Morton, R Brambilla, et al. Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling. Brain Behav Immun. 2014, 41: 65-81.
[69]
GJ Norman, K Karelina, N Zhang, et al. Stress and IL-1beta contribute to the development of depressive- like behavior following peripheral nerve injury. Mol Psychiatry. 2010, 15(4): 404-414.
[70]
Q Li, SB Liu, XC Zhu, et al. Hippocampal PKR/ NLRP1 inflammasome pathway is required for the depression-like behaviors in rats with neuropathic pain. Neuroscience. 2019, 412: 16-28.
[71]
H Al-Amin, R Sarkis, S Atweh, et al. Chronic dizocilpine or apomorphine and development of neuropathy in two animal models II: Effects on brain cytokines and neurotrophins. Exp Neurol. 2011, 228(1): 30-40.
[72]
E Egorova, A Starinets, A Tyrtyshnaia, et al. Hippocampal neurogenesis in conditions of chronic stress induced by sciatic nerve injury in the rat. Cells Tissues Organs (Print). 2019, 207(1): 58-68.
[73]
M Schäfers, CI Svensson, C Sommer, et al. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci. 2003, 23(7): 2517-2521.
[74]
S Ohtori, K Takahashi, H Moriya, et al. TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine. 2004, 29(10): 1082-1088.
[75]
M Zelenka, M Schäfers, C Sommer. Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain. 2005, 116(3): 257-263.
[76]
DA Berg, L Belnoue, HJ Song, et al. Neurotransmitter- mediated control of neurogenesis in the adult vertebrate brain. Development. 2013, 140(12): 2548-2561.
[77]
WC Covey, TA Ignatowski, PR Knight, et al. Brain- derived TNFalpha: involvement in neuroplastic changes implicated in the conscious perception of persistent pain. Brain Res. 2000, 859(1): 113-122.
[78]
TA Ignatowski, WC Covey, PR Knight, et al. Brain- derived TNFalpha mediates neuropathic pain. Brain Res. 1999, 841(1/2): 70-77.
[79]
K Starke. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977, 77: 1-124.
[80]
TA Ignatowski, R Sud, JL Reynolds, et al. The dissipation of neuropathic pain paradoxically involves the presence of tumor necrosis factor-alpha (TNF). Neuropharmacology. 2005, 48(3): 448-460.
[81]
NT Fiore, PJ Austin. Glial-cytokine-neuronal adaptations in the ventral hippocampus of rats with affective behavioral changes following peripheral nerve injury. Neuroscience. 2018, 390: 119-140.
[82]
N Kuzumaki, D Ikegami, S Imai, et al. Enhanced IL-1beta production in response to the activation of hippocampal glial cells impairs neurogenesis in aged mice. Synapse. 2010, 64(9): 721-728.
[83]
MM Li, CL Li, HJ Yu, et al. Lentivirus-mediated interleukin-1β (IL-1β) knock-down in the hippocampus alleviates lipopolysaccharide (LPS)-induced memory deficits and anxiety- and depression-like behaviors in mice. J Neuroinflammation. 2017, 14(1): 190.
[84]
LM Song, L Pei, SL Yao, et al. NLRP3 inflammasome in neurological diseases, from functions to therapies. Front Cell Neurosci. 2017, 11: 63.
[85]
T Mokhtari, M Akbari, F Malek, et al. Improvement of memory and learning by intracerebroventricular microinjection of T3 in rat model of ischemic brain stroke mediated by upregulation of BDNF and GDNF in CA1 hippocampal region. Daru. 2017, 25(1): 4.
[86]
KQ Nuseir, AY Altarifi, A Tasslaq, et al. Early and late anti nociceptive effects of sucrose on neonatal inflammatory pain in rats: Comparison to a non- steroidal anti-inflammatory drug. Physiol Behav. 2019, 206: 37-42.
[87]
S Eftekhari, S Mehrabi, M Soleimani, et al. BDNF modifies hippocampal KCC2 and NKCC1 expression in a temporal lobe epilepsy model. Acta Neurobiol Exp (Wars). 2014, 74(3): 276-287.
[88]
A Merighi, C Salio, A Ghirri, et al. BDNF as a pain modulator. Prog Neurobiol. 2008, 85(3): 297-317.
[89]
NM Sosanya, TH Garza, W Stacey, et al. Involvement of brain-derived neurotrophic factor (BDNF) in chronic intermittent stress-induced enhanced mechanical allodynia in a rat model of burn pain. BMC Neurosci. 2019, 20(1): 17.
[90]
A Latremoliere, CJ Woolf. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009, 10(9): 895-926.
[91]
JA Coull, S Beggs, D Boudreau, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature. 2005, 438(7070): 1017-1021.
[92]
F Boulle, DL van den Hove, SB Jakob, et al. Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry. 2012, 17(6): 584-596.
[93]
F Karege, G Perret, G Bondolfi, et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002, 109(2): 143-148.
Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 06 November 2019
Revised: 08 December 2019
Accepted: 15 December 2019
Published: 18 May 2020
Issue date: December 2019

Copyright

© The authors 2019

Acknowledgements

This work was supported by the National Natural Science Foundation of China (No. 31671141, No. 31822025), the Informatization Special Project of Chinese Academy of Sciences (No. XXH13506-306), and the Scientific Foundation project of Institute of Psychology, Chinese Academy of Sciences (No. Y6CX021008).

Rights and permissions

Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage)

Return